HKD 7.1
(-0.14%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 1.35 Billion CNY | 51.99% |
2022 | 892.17 Million CNY | -1.1% |
2021 | 902.13 Million CNY | 2.68% |
2020 | 878.54 Million CNY | 8.91% |
2019 | 806.7 Million CNY | 18.32% |
2018 | 681.82 Million CNY | 1.57% |
2017 | 671.25 Million CNY | 1.46% |
2016 | 661.58 Million CNY | 4.76% |
2015 | 631.52 Million CNY | -2.05% |
2014 | 644.76 Million CNY | 1.46% |
2013 | 635.49 Million CNY | 0.67% |
2012 | 628.23 Million CNY | 22.99% |
2011 | 513.27 Million CNY | 31.52% |
2010 | 390.25 Million CNY | 32.02% |
2009 | 295.6 Million CNY | 14.05% |
2008 | 259.19 Million CNY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 705.95 Million CNY | 0.0% |
2023 FY | - CNY | 51.99% |
2023 Q4 | 604.98 Million CNY | 0.0% |
2023 Q2 | 611.5 Million CNY | 0.0% |
2022 Q2 | 447.64 Million CNY | 0.0% |
2022 Q4 | 444.53 Million CNY | 0.0% |
2022 FY | - CNY | -1.1% |
2021 FY | - CNY | 2.68% |
2021 Q2 | 475.33 Million CNY | 0.0% |
2021 Q4 | 426.79 Million CNY | 0.0% |
2020 Q2 | 437.17 Million CNY | 0.0% |
2020 Q4 | 441.37 Million CNY | 0.0% |
2020 FY | - CNY | 8.91% |
2019 Q2 | 443.48 Million CNY | 0.0% |
2019 Q4 | 363.22 Million CNY | 0.0% |
2019 FY | - CNY | 18.32% |
2018 FY | - CNY | 1.57% |
2018 Q4 | 319.79 Million CNY | 0.0% |
2018 Q2 | 362.02 Million CNY | 0.0% |
2017 Q2 | 383.67 Million CNY | 0.0% |
2017 FY | - CNY | 1.46% |
2017 Q4 | 287.58 Million CNY | 0.0% |
2016 Q4 | 305.48 Million CNY | 0.0% |
2016 FY | - CNY | 4.76% |
2016 Q2 | 356.1 Million CNY | 0.0% |
2015 Q4 | 277.9 Million CNY | 0.0% |
2015 Q2 | 353.61 Million CNY | 0.0% |
2015 FY | - CNY | -2.05% |
2014 Q2 | 373.09 Million CNY | 0.0% |
2014 FY | - CNY | 1.46% |
2014 Q4 | 271.67 Million CNY | 0.0% |
2013 Q4 | 287.21 Million CNY | 0.0% |
2013 FY | - CNY | 0.67% |
2013 Q2 | 348.28 Million CNY | 0.0% |
2012 Q1 | 154.58 Million CNY | 0.0% |
2012 Q4 | 182.82 Million CNY | 18.26% |
2012 Q3 | 154.58 Million CNY | 0.0% |
2012 Q2 | 154.58 Million CNY | 0.0% |
2012 FY | - CNY | 22.99% |
2011 Q4 | 154.58 Million CNY | 21.78% |
2011 Q3 | 126.94 Million CNY | 0.0% |
2011 FY | - CNY | 31.52% |
2011 Q1 | 126.94 Million CNY | 0.0% |
2011 Q2 | 126.94 Million CNY | 0.0% |
2010 Q3 | 96.05 Million CNY | 0.0% |
2010 Q2 | 96.05 Million CNY | 0.0% |
2010 Q4 | 126.94 Million CNY | 32.16% |
2010 FY | - CNY | 32.02% |
2010 Q1 | 96.05 Million CNY | 0.0% |
2009 Q2 | 62.49 Million CNY | 0.0% |
2009 Q4 | 96.05 Million CNY | 53.69% |
2009 Q3 | 62.49 Million CNY | 0.0% |
2009 FY | - CNY | 14.05% |
2009 Q1 | 62.49 Million CNY | 0.0% |
2008 FY | - CNY | 0.0% |
2008 Q1 | 52.73 Million CNY | 0.0% |
2008 Q2 | 52.73 Million CNY | 0.0% |
2008 Q3 | 52.73 Million CNY | 0.0% |
2008 Q4 | 62.49 Million CNY | 18.53% |
2007 Q4 | 52.73 Million CNY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Starlite Holdings Limited | 71.42 Million HKD | -1792.776% |
Litu Holdings Limited | 1.21 Million HKD | -111450.413% |
Touyun Biotech Group Limited | -228.56 Million HKD | 691.505% |
Champion Alliance International Holdings Limited | 35.89 Million HKD | -3666.201% |
Huaxi Holdings Company Limited | -31.47 Million HKD | 4394.898% |